期刊文献+

重症监护病房血流感染的危险因素及预后分析 被引量:27

Risk and prognostic factor analysis of bloodstream infection in intensive care unit
下载PDF
导出
摘要 目的探讨重症监护病房(ICU)血流感染的危险因素及影响血流感染预后的相关因素分析。方法回顾性分析2014年10月-2017年10月河北衡水市哈励逊国际和平医院ICU诊断为血流感染的住院患者,同时选取210例血培养阴性患者资料,比较血培养阳性与阴性患者的生理指标与实验室参数,采用多因素logistic回归分析发生血流感染的危险因素。将189例血流感染患者按血培养采集后30 d内预后分为存活组(121例)和死亡组(68例),分析影响血流感染30d预后的相关危险因素。结果 3年间ICU发生血流感染189例,革兰阴性杆菌118例,革兰阳性球菌65例,真菌6例。单因素分析显示,先前接受碳青霉烯类或第三代头孢菌素治疗、中心静脉置管、住院天数≥2周、机械通气为发生血流感染的危险因素,差异有统计学意义(P<0.05)。多因素logistic回归分析显示,之前接受碳青霉烯类或第三代头孢菌素治疗(OR=20.15)、中心静脉置管(OR=25.34)、机械通气(OR=18.26)为ICU血流感染的独立危险因素。单因素分析显示,应用碳青霉烯类药物或第三代头孢菌素治疗、混合感染或感染性休克、多重耐药(MDR)菌感染和高急性生理与慢性健康评分(APACHEⅡ评分)是影响血流感染30d预后危险因素,差异有统计学意义(P<0.05)。多因素logistic回归分析显示,混合感染或感染性休克(OR=15.30)、MDR菌感染(OR=10.75)和高APACHEⅡ评分(OR=13.70)为影响血流感染30 d预后的独立危险因素。结论之前接受碳青霉烯类或第三代头孢菌素治疗、中心静脉置管、机械通气是ICU血流感染的独立危险因素,混合感染或感染性休克、MDR菌感染和高APACHEⅡ评分是影响血流感染30d预后的独立危险因素。 Objective To investigate the risk factors and prognostic factors of bloodstream infection in intensive care unit(ICU). Methods The data of patients with bloodstream infection in ICU of Harrison International Peace Hospital from October 2014 to October 2017 were retrospectively analyzed and 210 patients with negative blood culture were selected. The physiological and laboratory parameters were compared between patients with positive blood culture and those with negative blood culture. Multivariate logistic regression analysis was used to screen the risk factors of bloodstream infection. Overall, 189 patients with bloodstream infection were classified into survival group(n=121) and death group(n=68) according to the survival status within 30 days after blood culture. The risk factors related to 30-day patient outcome following bloodstream infection were analyzed. Results A total of 189 cases of bloodstream infection were identified in the ICU during the 3-year period, including 118 cases due to gram-negative bacilli, 65 cases caused by gram-positive cocci, and 6 cases due to fungi. Univariate analysis showed that prior use of carbapenem or third generation cephalosporins, central venous catheterization, length of hospital stay≥2 weeks, and mechanical ventilation were the risk factors of bloodstream infection(P<0.05). Multivariate logistic regression analysis showed that prior use of carbapenems or third-generation cephalosporins(OR=20.15), central venous catheterization(OR=25.34), and mechanical ventilation(OR=18.26) were independent risk factors for bloodstream infection in ICU patients. Univariate analysis showed that prior use of carbapenem or third generation cephalosporins, mixed infection or septic shock, multi-drug resistant bacterial infection, and high APACHE Ⅱ(acute physiological and chronic health evaluation system Ⅱ) score were significant risk factors for 30-day mortality following bloodstream infection(P<0.05). Multivariate logistic regression analysis showed mixed infection or septic shock(OR=15.30), multi-drug resistant bacterial infection(OR=10.75) and high APACHE Ⅱ score(OR=13.70) were independent risk factors for 30-day mortality following bloodstream infection. Conclusions Prior use of carbapenem or third generation cephalosporins, central venous catheterization and mechanical ventilation are independent risk factors for bloodstream infection in ICU patients. Mixed infection or septic shock, multi-drug resistant bacterial infection, and high APACHE Ⅱ score are independent risk factors for 30-day mortality following bloodstream infection.
作者 刘兆玮 马科 胡景玉 李庆禄 LIU Zhaowei;MAKe;HU Jingyu;LI Qinglu(Department of Laboratory Medicine,Harrison International Peace Hospital,Hengshui Hebei 053000,China)
出处 《中国感染与化疗杂志》 CAS CSCD 北大核心 2019年第1期12-17,共6页 Chinese Journal of Infection and Chemotherapy
关键词 重症监护病房 血流感染 危险因素 LOGISTIC回归分析 预后分析 intensive care unit bloodstream infection risk factor logistic regression analysis prognostic analysis
  • 相关文献

参考文献9

二级参考文献94

  • 1王鸣,彭炜,蔡敏,季刚.外科重症监护室645例脓毒症患者临床流行病学调查[J].中国危重病急救医学,2006,18(2):74-77. 被引量:31
  • 2Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 3Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 4Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.
  • 5Brink AJ. Feldman C. Grolman DC. et al. Appropriate use of the carbapenems[J]. S Afr Med J. 2004. 94 (10 Pt 2): 857-861.
  • 6Chen S. Hu F. Zhang X. et al. Independent emergence of colistin-resistant Enterobacteriaceae clinical isolates without colistin treatrnentj]]. J Clin Microbiol , 2011. 49( 11): 4022- 4023.
  • 7van Duin D. Kaye KS. Neuner EA. et al. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes[J]. Diagn Microbiol Infect Dis. 2013. 75(2): l1S-120.
  • 8Daikos GL. Tsaousi S. Tzouvelekis LS. et al. Carbapenemaseproducing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems [J]. Antimicrob Agents Chernother , 2014.58 (4): 2322-2328.
  • 9Tascini C. Tagliaferri E. Giani T. et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPCproducing Klebsiella pneumoniae [J]. Antimicrob Agents Chernother , 2013. 57 (8): 3990-3993.
  • 10Pulcini C. Bush K. Craig WA. et al. Forgotten Antibiotics: an Inventory in Europe. the United States. Canada. and Australia[J]. Clin Infect Dis. 2012. 54(2): 268-274.

共引文献6801

同被引文献285

引证文献27

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部